| 2026-08-13 | 10-Q | 10.1 | Exclusive (Equity) Agreement, between the Company and The Board of Trustees of the Leland Stanford Junior University, dated August 8, 2016.* |
|---|
| 2025-08-14 | 10-Q | 10.1 | Priority Review Voucher Asset Purchase Agreement dated May 9, 2025.* |
|---|
| 2025-07-18 | 8-K | 10.1 | First Amendment to Loan and Security Agreement and Supplement, by and among Abeona Therapeutics Inc., MacroChem Corporation, Abeona Therapeutics LLC, Avenue Venture Opportunities Fund, L.P., as Agent, and Avenue Venture Opportunities Fund II, L.P., dated as of July 18, 2025. |
|---|
| 2024-01-08 | 8-K | 10.2 | Supplement to the Loan and Security Agreement, by and among Abeona Therapeutics, Inc., MacroChem Corporation, Abeona Therapeutics LLC, Avenue Venture Opportunities Fund, L.P., as Agent, and Avenue Venture Opportunities Fund II, L.P., dated as of January 8, 2024. |
|---|
| 2024-01-08 | 8-K | 10.1 | Loan and Security Agreement, by and among Abeona Therapeutics, Inc., MacroChem Corporation, Abeona Therapeutics LLC, Avenue Venture Opportunities Fund, L.P., as Agent, and Avenue Venture Opportunities Fund II, L.P., dated as of January 8, 2024. |
|---|
| 2023-08-08 | 10-Q | 10.5 | Retention Bonus Letter, dated June 15, 2023, to Brendon O’Malley, Ph.D. |
|---|
| 2023-08-08 | 10-Q | 10.4 | Retention Bonus Letter, dated June 15, 2023, to Joseph Vazzano. |
|---|
| 2023-08-08 | 10-Q | 10.3 | Retention Bonus Letter, dated June 15, 2023, to Vishwas Seschadri, Ph.D. |
|---|
| 2023-07-03 | 8-K | 10.1 | Securities Purchase Agreement, dated July 3, 2023 |
|---|
| 2022-11-03 | 8-K | 10.1 | Form of Registration Rights Agreement Securities Purchase Agreement dated November 3, 2022 Press Release dated November 3, 2022 Cover Page Interactive Data File (embedded within the Inline XBRL document) |
|---|
| 2022-08-11 | 10-Q | 10.3 | License Agreement by and between Abeona Therapeutics Inc. and Ultragenyx Pharmaceutical Inc., dated May 16, 2022. |
|---|
| 2022-05-13 | 10-Q | 10.1 | Letter Agreement, dated February 28, 2022, between the Company and Joseph Vazzano. |
|---|
| 2022-05-02 | 8-K | 10.2 | Form of Registration Rights Agreement by and among Abeona Therapeutics Inc. and the investors named therein, dated April 29, 2022 |
|---|
| 2022-05-02 | 8-K | 10.1 | Form of Securities Purchase Agreement between Abeona Therapeutics Inc. and the investors thereto, dated April 29, 2022 |
|---|
| 2022-03-31 | 10-K | 10.14 | Settlement Agreement and Mutual Release, dated November 12, 2021, between the Company and REGENXBIO Inc. |
|---|
| 2022-03-31 | 10-K | 10.11 | Letter Agreement, dated September 16, 2021, between the Company and Brendan O’Malley |
|---|
| 2022-03-31 | 10-K | 10.6 | Letter Agreement, dated October 6, 2021, between the Company and Vishwas Seshadri |
|---|
| 2021-11-15 | 10-Q | 10.1 | Letter Agreement, dated August 10, 2021, between the Company and Edward Carr. |
|---|
| 2021-05-17 | 10-Q | 10.2 | Letter Agreement, dated March 19, 2021, between the Company and Michael Amoroso. |
|---|
| 2021-05-17 | 10-Q | 10.1 | Amended and Restated Letter Agreement, dated January 27, 2021, between the Company and Michael Amoroso. |
|---|
| 2020-10-30 | 8-K | 10.1 | Letter Agreement, dated October 26, 2020, between Abeona Therapeutics Inc. and Michael Amoroso |
|---|
| 2020-10-16 | 8-K | 10.1 | Form of Indemnification Agreement |
|---|
| 2020-08-10 | 10-Q | 10.1 | Amendment No. 3, dated April 14, 2020, to Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh. |
|---|
| 2020-06-23 | 8-K | 10.1 | Offer Letter between Abeona Therapeutics Inc. and Edward Carr, dated June 18, 2020 |
|---|
| 2020-05-06 | 10-Q | 10.4 | Amendment No. 2, dated March 31, 2020, to Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh. |
|---|
| 2020-05-06 | 10-Q | 10.3 | Letter Agreement, dated March 13, 2020, between the Company and Christine Berni Silverstein. |
|---|
| 2020-05-06 | 10-Q | 10.2 | Amendment No. 1, dated March 6, 2020, to Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh. |
|---|
| 2020-05-06 | 10-Q | 10.1 | Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh. |
|---|
| 2020-04-21 | 8-K | 10.1 | Offer Letter, dated April 15, 2020, between Abeona Therapeutics Inc. and Brian J.G. Pereira, M.D. |
|---|
| 2019-12-23 | 8-K | 10.1 | Letter Agreement regarding Certain Purchaser Rights, dated December 20, 2019, among the Company, Biomedical Value Fund, L.P., Biomedical Offshore Value Fund, Ltd., and GEF-SMA, L.P. |
|---|
| 2019-11-12 | 10-Q | 10.4 | First Amendment to License Agreement, dated November 1, 2019, between the Company and REGENXBIO Inc. |
|---|
| 2019-11-12 | 10-Q | 10.3 | Letter Agreement, dated September 12, 2019, amending Offer Letter between the Company and Edward Carr, dated November 9, 2018. |
|---|
| 2019-11-12 | 10-Q | 10.2 | Letter Agreement, dated September 12, 2019, amending Offer Letter between the Company and Christine Berni Silverstein, dated January 8, 2019. |
|---|
| 2019-11-12 | 10-Q | 10.1 | Letter Agreement, dated September 12, 2019, amending Offer Letter between the Company and João Siffert, M.D., dated February 11, 2019. |
|---|
| 2019-03-18 | 10-K | 10.18 | License Agreement, dated November 4, 2018, between the Company and REGENXBIO Inc. |
|---|
| 2019-02-13 | 8-K | 10.1 | Offer Letter, dated February 11, 2019, by and between Abeona Therapeutics Inc. and João Siffert, M.D. |
|---|
| 2019-01-10 | 8-K | 10.1 | Offer Letter, dated January 8, 2019, by and between Abeona Therapeutics Inc. and Christine Berni Silverstein |
|---|
| 2018-11-30 | 8-K | 10.3 | Separation Agreement between Abeona Therapeutics, Inc. and F. Carsten Thiel, Ph. D., dated November 29, 2018. |
|---|
| 2018-11-30 | 8-K | 10.2 | Letter Agreement between Abeona Therapeutics, Inc. and João Siffert, M.D., dated November 29, 2018. |
|---|
| 2018-11-30 | 8-K | 10.1 | Letter Agreement between Abeona Therapeutics, Inc. and João Siffert, M.D., dated September 28, 2018. |
|---|
| 2018-11-09 | 8-K | 10.1 | Offer Letter, effective October 19, 2018, by and between Abeona Therapeutics Inc. and Edward Carr |
|---|
| 2018-10-09 | 8-K/A | 10.1 | Letter of Agreement dated October 5, 2018 by and between the Company and Stephen B. Thompson |
|---|
| 2018-10-05 | 8-K | 10.1 | Letter of Agreement and General Release dated October 1, 2018 between the Company and Jeffrey Davis |
|---|
| 2018-05-10 | 10-Q | 10.1 | Employment Agreement dated March 29, 2018 between the Company and F. Carsten Thiel |
|---|
| 2016-08-15 | 10-Q | 10.1 | Form of Indemnification Agreement, between us and directors and officers of the Company |
|---|
| 2015-11-16 | 10-Q | 10.1 | Employment Agreement dated May 6, 2015 between Registrant and Timothy J. Miller |
|---|
| 2015-08-14 | 10-Q/A | 10.5 | Form of Securities Purchase Agreement dated May 6, 2015. |
|---|
| 2015-08-14 | 10-Q/A | 10.4 | Form of Common Stock Purchase Agreement, dated April 1, 2015. |
|---|
| 2015-08-14 | 10-Q/A | 10.1 | Agreement and Plan of Merger, dated May 5, 2015, by and among the Company, Plasmatech Merger Sub Inc., Abeona Therapeutics LLC and Paul A. Hawkins, in his capacity as Member Representative |
|---|
| 2015-08-14 | 10-Q | 10.5 | Form of Securities Purchase Agreement dated May 6, 2015. |
|---|
| 2015-08-14 | 10-Q | 10.4 | Form of Common Stock Purchase Agreement, dated April 1, 2015. |
|---|
| 2015-08-14 | 10-Q | 10.1 | Agreement and Plan of Merger, dated May 5, 2015, by and among the Company, Plasmatech Merger Sub Inc., Abeona Therapeutics LLC and Paul A. Hawkins, in his capacity as Member Representative |
|---|
| 2015-08-03 | 8-K | 10.1 | Form of Purchase Agreement |
|---|
| 2015-07-31 | 8-K | 10.1 | Letter agreement dated July 31, 2015 between the Company and Sabby Healthcare and Sabby Volatility |
|---|
| 2015-03-31 | 10-K | 10.29 | Amendment No. 1 to License Agreement, dated September 19, 2014, by and between us and Plasma Technologies, LLC, dated January 23, 2015. |
|---|
| 2014-12-03 | 8-K | 10.35 | UNSECURED GRID NOTE DATED DECEMBER 1, 2014 |
|---|
| 2014-10-23 | 8-K | 10.33 | SHARE EXCHANGE AGREEMENT FOR SERIES B PREFERRED STOCK |
|---|
| 2014-09-24 | 8-K | 10.32 | EMPLOYMNET LETTER AGREEMENT HARRISON WEHNER |
|---|
| 2014-09-24 | 8-K | 10.31 | EMPLOYMENT LETTER AGREEMENT SCOTT SCHORER |
|---|
| 2014-09-24 | 8-K | 10.30 | LICENSE AGREEMENT - PLASMA TECHNOLOGIES LLC |
|---|
| 2013-08-14 | 10-Q | 10.16 | LICENSE AGREEMENT AMAG PHARMACEUTICALS |
|---|
| 2012-10-26 | 8-K | 10.4 | CERTIFICATE OF DESIGNATIONS, RIGHTS AND PREFERENCES OF SERIES B CUMULATIVE CONVERTIBLE PREFERRED STOCK OF ACCESS PHARMACEUTICALS, INC. |
|---|
| 2012-10-26 | 8-K | 10.3 | FORM OF WARRANT |
|---|
| 2012-10-26 | 8-K | 10.2 | INVESTOR RIGHTS AGREEMENT |
|---|
| 2012-10-26 | 8-K | 10.1 | PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT |
|---|
| 2011-11-10 | 8-K | 10.3 | FORM OF WARRANT - FIVE YEAR WARRANT |
|---|
| 2011-11-10 | 8-K | 10.2 | FORM OF WARRANT - TWO AND ONE HALF YEAR WARRANT |
|---|
| 2011-11-10 | 8-K | 10.1 | SECURITIES PURCHASE AGREEMENT |
|---|
| 2011-11-07 | 8-K | 10.1 | PRESS RELEASE DATED NOVEMBER 3, 2011 |
|---|
| 2010-12-14 | 8-K | 10.2 | FORM OF COMMON STOCK WARRANT |
|---|
| 2010-12-14 | 8-K | 10.1 | FORM OF SECURITES PURCHASE AGREEMENT |
|---|
| 2010-03-23 | 10-K | 10.9 | RIGHTS AGREEMENT AMENDED |
|---|
| 2010-02-08 | 8-K | 10.31 | Employment Agreement by and between the Company and Dr. David Nowotnik, dated January 29, 2010. |
|---|